Amedisys Home Health Of Lexington | |
714 Southlake Drive Suite 250, Lexington, South Carolina 29072 | |
(803) 720-5244 | |
Name | Amedisys Home Health Of Lexington |
---|---|
Location | 714 Southlake Drive Suite 250, Lexington, South Carolina |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 427039 |
Ownership Type | Proprietary |
Service Area Zip Codes | 29001, 29003, 29006, 29009, 29010, 29018, 29020, 29030, 29032, 29033, 29036, 29037, 29038, 29039, 29040, 29042, 29046, 29047, 29048, 29051, 29053, 29054, 29059, 29062, 29063, 29070, 29072, 29073, 29075, 29080, 29081, 29104, 29105, 29107, 29108, 29112, 29113, 29114, 29115, 29116, 29118, 29123, 29125, 29126, 29127, 29128, 29129, 29133, 29135, 29137, 29138, 29142, 29145, 29146, 29150, 29153, 29154, 29160, 29163, 29164, 29166, 29168, 29169, 29170, 29172, 29177, 29178, 29210, 29212, 29223, 29355, 29432, 29436, 29481, 29550, 29801, 29802, 29803, 29805, 29808, 29809, 29812, 29817, 29821, 29822, 29824, 29826, 29828, 29829, 29831, 29832, 29834, 29835, 29839, 29841, 29842, 29843, 29845, 29847, 29851, 29853, 29856, 29860, 29861 |
NPI Number | 1760430375 |
Organization Name | AMEDISYS SC, LLC |
Doing Business As | AMEDISYS HOME HEALTH OF LEXINGTON |
Address | 714 S Lake Dr, Suite 250, Lexington, SC 29072 |
Phone Number | 803-359-2253 |
News Archive
The process researchers use to generate induced pluripotent stem cells (iPSCs)-a special type of stem cell that can be made in the lab from any type of adult cell-is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors.
Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
President Obama's appeal to members of Congress to not walk away from health care reform and the millions of Americans who are counting on it provides hope to the many heart disease and stroke patients who are struggling to get the care they need or are one step away from medical bankruptcy.
› Verified 9 days ago
Quality Rating: |
News Archive
The process researchers use to generate induced pluripotent stem cells (iPSCs)-a special type of stem cell that can be made in the lab from any type of adult cell-is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors.
Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
President Obama's appeal to members of Congress to not walk away from health care reform and the millions of Americans who are counting on it provides hope to the many heart disease and stroke patients who are struggling to get the care they need or are one step away from medical bankruptcy.
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.1 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.9 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.8 | 99.6 |
How often the home health team checked patients for depression | 91.4 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 89.5 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.9 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 95.4 | 96.4 |
News Archive
The process researchers use to generate induced pluripotent stem cells (iPSCs)-a special type of stem cell that can be made in the lab from any type of adult cell-is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors.
Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
President Obama's appeal to members of Congress to not walk away from health care reform and the millions of Americans who are counting on it provides hope to the many heart disease and stroke patients who are struggling to get the care they need or are one step away from medical bankruptcy.
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 92.1 | 79.6 |
How often patients got better at getting in and out of bed | 94.3 | 81.1 |
How often patients got better at bathing | 91.4 | 82.3 |
How often patients’ breathing improved | 95.7 | 82.8 |
How often patients’ wounds improved or healed after an operation | 96.5 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 89.4 | 75 |
How often home health patients had to be admitted to the hospital | 15.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15.4 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 97.5 | 94 |
News Archive
The process researchers use to generate induced pluripotent stem cells (iPSCs)-a special type of stem cell that can be made in the lab from any type of adult cell-is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors.
Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
President Obama's appeal to members of Congress to not walk away from health care reform and the millions of Americans who are counting on it provides hope to the many heart disease and stroke patients who are struggling to get the care they need or are one step away from medical bankruptcy.
› Verified 9 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
The process researchers use to generate induced pluripotent stem cells (iPSCs)-a special type of stem cell that can be made in the lab from any type of adult cell-is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors.
Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
President Obama's appeal to members of Congress to not walk away from health care reform and the millions of Americans who are counting on it provides hope to the many heart disease and stroke patients who are struggling to get the care they need or are one step away from medical bankruptcy.
› Verified 9 days ago
The patient survey data of Amedisys Home Health Of Lexington is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 85 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 86 | 78 |
News Archive
The process researchers use to generate induced pluripotent stem cells (iPSCs)-a special type of stem cell that can be made in the lab from any type of adult cell-is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors.
Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
President Obama's appeal to members of Congress to not walk away from health care reform and the millions of Americans who are counting on it provides hope to the many heart disease and stroke patients who are struggling to get the care they need or are one step away from medical bankruptcy.
› Verified 9 days ago
Amedisys Home Health Of Lexington Location: 714 Southlake Drive Suite 250, Lexington, South Carolina 29072 Ratings: Phone: (803) 720-5244 |